相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population
Stephen L. Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
Tim F. Greten et al.
BMC CANCER (2010)
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Fidel-David Huitzil-Melendez et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Challenge of Prognosis and Staging for Hepatocellular Carcinoma
Jorge A. Marrero et al.
ONCOLOGIST (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Prognostic scores for hepatocellular carcinoma: none is the winner
Calogero Camma et al.
LIVER INTERNATIONAL (2009)
Prognosis of advanced hepatocellular carcinoma:: comparison of three staging systems in two French clinical trials
S. Collette et al.
ANNALS OF ONCOLOGY (2008)
A New Prognostic Score System in Patients With Advanced Hepatocellular Carcinoma Not Amendable to Locoregional Therapy Implication for Patient Selection in Systemic Therapy Trials
Thomas Yau et al.
CANCER (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prognostic value and clinical relevance of the 6th edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma
Hao-Jan Lei et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis
A Linden
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2006)
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma
W Yeo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
R Tateishi et al.
GUT (2005)
Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score
M Kudo et al.
HEPATOLOGY (2004)
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
M Kudo et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Liver Italian Program staging system - A study based on 926 patients
TWT Leung et al.
CANCER (2002)
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
M Malinchoc et al.
HEPATOLOGY (2000)
分享论文
